Slim Belly (Aussia Pharma)
Product Name
Slim Belly
Sponsor
ARTG
393315
Date of review outcome
Date cancellation takes effect
Date of publication
Sep-2023
Outcome
Medicine is no longer permitted to be supplied
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, follow the recommended actions below.
What action should consumers take?
Consider whether this medicine is right for you based on it potentially not working as expected in relation to abdominal fat loss.
Review scope
Targeted
Information reviewed
ARTG Record
Issues related to safety
The name for this medicine implied that it could aid in abdominal fat loss. There are known links between abdominal fat and serious conditions such as diabetes and heart disease. This medicine's name has the potential to lead consumers with these conditions to delay access to timely medical advice or treatment resulting in adverse outcomes.
However, as this medicine was never supplied in Australia, it is unlikely to pose an immediate risk to consumer health and safety.
However, as this medicine was never supplied in Australia, it is unlikely to pose an immediate risk to consumer health and safety.
Issues related to efficacy
The name for this medicine implied that it could aid in abdominal fat loss. However, this claim was not covered by the sponsor's certification that they held evidence to substantiate it.
Actions taken during the review
The TGA required the sponsor to correct the issue with this medicine. The sponsor did not sufficiently address the issue. The TGA cancelled this medicine and withdrew permission for further supply.
Grounds for cancellation
It appears to the Secretary that the presentation of the goods in the case of listed goods is unacceptable (paragraph 30(2)(aa) of the Act).